Article
Extended HPV Genotyping for Risk Assessment of Cervical Intraepithelial Neoplasia Grade 2/3 or Worse in a Cohort Study.
Journal of the National Comprehensive Cancer Network : JNCCN - 1 Aug 2022
Li Xiao, Rao Xuan, Wei Ming-Jing, Lu Wei-Guo, Xie Xing, Wang Xin-Yu
Abstract excerpt
BACKGROUND: We sought to identify the absolute risk of specific HPV genotype for cervical intraepithelial neoplasia grade 2/3 or worse (CIN2+/3+) and to develop a risk-based management strategy in an HPV-positive population. METHODS: HPV genotyping was performed based on a 3-year cervical cancer screening cohort. The study endpoints were histologic CIN2+/3+. The prevalence of specific HPV genotype was calculated...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
